|
|
Vaccine Detail
|
MG1-hDCT Vaccine |
| Vaccine Information |
- Vaccine Name: MG1-hDCT Vaccine
- Target Pathogen: Cancer
- Target Disease: Cancer
- Vaccine Ontology ID: VO_0004764
- Type: Recombinant vector vaccine
- Status: Research
- Host Species for Licensed Use: Baboon
- MAGE-1
gene engineering:
- Type: Recombinant protein preparation
- Description: (Sang et al., 2011)
- Detailed Gene Information: Click Here.
- Vector: Maraba virus vaccine vector
- Preparation: (Pol et al., 2014) an attenuated Maraba strain, defined as MG1, to express a melanoma-associated tumor antigen.
- Immunization Route: Intramuscular injection (i.m.)
|
| Host Response |
|
|
| References |
Pol et al., 2014: Pol JG, Zhang L, Bridle BW, Stephenson KB, Rességuier J, Hanson S, Chen L, Kazdhan N, Bramson JL, Stojdl DF, Wan Y, Lichty BD. Maraba virus as a potent oncolytic vaccine vector. Molecular therapy : the journal of the American Society of Gene Therapy. 2014; 22(2); 420-429. [PubMed: 24322333].
Sang et al., 2011: Sang M, Wang L, Ding C, Zhou X, Wang B, Wang L, Lian Y, Shan B. Melanoma-associated antigen genes - an update. Cancer letters. 2011; 302(2); 85-90. [PubMed: 21093980].
|
|
